Loading...

China Oncology

30 July 2024, Volume 34 Issue 7
Cover and contents

2024 Issue 7 Cover

Abstract ( 125) PDF (6865KB) ( 217 )

Contents of Issue 7, 2024

2024, 34 (7): 2-2.

Abstract ( 34) PDF (10552KB) ( 123 )

Specialist' Commentary

Clinical consideration of two key questions in assessing menopausal status of female breast cancer patients

ZHANG Jian

2024, 34 (7): 619-627. doi: 10.19401/j.cnki.1007-3639.2024.07.001

Abstract ( 298) PDF (1144KB) ( 867 ) HTML ( 15 )

Article

A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis

WANG Manli, CHEN Hui, DUAN Zhi, XU Qimei, LI Zhen

2024, 34 (7): 628-638. doi: 10.19401/j.cnki.1007-3639.2024.07.002

Abstract ( 168) PDF (1719KB) ( 796 ) HTML ( 11 )

Optimization study of CAR-T cell expansion targeting CD99

WANG Yixuan, YU Miao, ZHAO Jiaxuan, ZHAO Fenfang, ZENG Yi, WANG Youyong, ZHU Haichuan, ZHANG Tongcun, SHI Jiangzhou

2024, 34 (7): 639-649. doi: 10.19401/j.cnki.1007-3639.2024.07.003

Abstract ( 181) PDF (2103KB) ( 776 ) HTML ( 16 )

Study on the mechanism of mitochondrial dysfunction and CPT1A/ERK signal transduction pathway regulating malignant behavior in breast cancer

JIANG Dan, SONG Guoqing, WANG Xiaodan

2024, 34 (7): 650-658. doi: 10.19401/j.cnki.1007-3639.2024.07.004

Abstract ( 206) PDF (1509KB) ( 779 ) HTML ( 9 )

An exploratory study on the perioperative treatment of locally advanced gastric cancer with combination of penpulimab, anlotinib and chemotherapy

LIU Shuai, ZHANG Kai, ZHANG Xiaoqing, LUAN Wei

2024, 34 (7): 659-668. doi: 10.19401/j.cnki.1007-3639.2024.07.005

Abstract ( 187) PDF (1150KB) ( 741 ) HTML ( 10 )

Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma

LIAO Ziyi, PENG Yang, ZENG Beilei, MA Yingying, ZENG Li, GAN Kelun, MA Daiyuan

2024, 34 (7): 669-679. doi: 10.19401/j.cnki.1007-3639.2024.07.006

Abstract ( 148) PDF (1671KB) ( 803 ) HTML ( 4 )

Correlation analysis of PSMA PET/CT-derived parameters and circulating tumor DNA features in patients with hormone-sensitive prostate cancer

PAN Jian, YE Dingwei, ZHU Yao, WANG Beihe

2024, 34 (7): 680-685. doi: 10.19401/j.cnki.1007-3639.2024.07.007

Abstract ( 185) PDF (1464KB) ( 761 ) HTML ( 8 )

Review

Application progress of oncolytic virus combined with immunotherapy in the treatment of malignant tumors

LIANG Yingyun, CHEN Jianhua

2024, 34 (7): 686-694. doi: 10.19401/j.cnki.1007-3639.2024.07.008

Abstract ( 289) PDF (1074KB) ( 501 ) HTML ( 36 )

Clinical research progress of intrathecal therapy in the treatment of leptomeningeal metastasis

HUANG Sijie, KANG Xun, LI Wenbin

2024, 34 (7): 695-701. doi: 10.19401/j.cnki.1007-3639.2024.07.009

Abstract ( 457) PDF (1057KB) ( 401 ) HTML ( 17 )

Guideline and Concensus

Expert consensus of 177Lu-labeled PSMA radioligand therapy for clinical practice of prostate cancer (2024 edition)

Cancer Nuclear Medicine Committee of China Anti-Cancer Association, Chinese Association of Nuclear Medicine Physicians

2024, 34 (7): 702-714. doi: 10.19401/j.cnki.1007-3639.2024.07.010

Abstract ( 594) PDF (1116KB) ( 491 ) HTML ( 18 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat